Cocrystal Pharma, Inc. Long Term Debt

Quick Answer

Cocrystal Pharma, Inc. reported Long Term Debt of $49.94 million for the year ending 2015.

  • Cocrystal Pharma, Inc. showed a decrease of -23.5% in Long Term Debt from 2014 to 2015.
  • This data is from Cocrystal Pharma, Inc.'s annual report (Form 10-K), filed with the SEC on March 15, 2016.
  • XBRL data for this metric is available from 2014 to 2015 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Historical annual values: Fiscal year 2015: $49.94 million | Fiscal year 2014: $65.26 million.
  • Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: